How to train glioma cells to die: molecular challenges in cell death Jeffrey WojtonWalter Hans MeisenBalveen Kaur Topic Review 05 November 2015 Pages: 377 - 384
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma Tina DasguptaAleksandra K. OlowDaphne A. Haas-Kogan Laboratory Investigation 18 September 2015 Pages: 385 - 393
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma Tina DasguptaAleksandra K. OlowDaphne A. Haas-Kogan Erratum 19 January 2016 Pages: 395 - 395
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway Harshil D. DhruvAlison RoosNhan L. Tran Laboratory Investigation 12 November 2015 Pages: 397 - 404
ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation Guiyan XuJian Yi Li Laboratory Investigation 02 November 2015 Pages: 405 - 413
Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice Noah C. JenkinsGanesh RaoDaniel W. Fults Laboratory Investigation 30 October 2015 Pages: 415 - 424
Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells Richard E. KastSusana RamiroMiguel Muñoz Laboratory Investigation 24 November 2015 Pages: 425 - 431
The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain Sadhana JacksonNicole M. AndersStuart A. Grossman Laboratory Investigation 01 December 2015 Pages: 433 - 439
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas Umberto NenchaAmithys RahimianMarc Sanson Laboratory Investigation 25 November 2015 Pages: 441 - 446
Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity Leslie L. MuldoonMichael A. PagelEdward A. Neuwelt Laboratory Investigation 02 December 2015 Pages: 447 - 454
XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression Yaohua LiuXu HouShiguang Zhao Laboratory Investigation 17 December 2015 Pages: 455 - 462
Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma Katerina DeikeBenedikt WiestlerAlexander Radbruch Clinical Study 30 October 2015 Pages: 463 - 472
Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas David TaïebAnne BarlierPhilippe Metellus Clinical Study 29 October 2015 Pages: 473 - 481
Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery Samuel M. ShinBenjamin T. CooperDouglas Kondziolka Clinical Study 31 October 2015 Pages: 483 - 491
Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients Joanna SochaLucyna KepkaElena Fidarova Clinical Study 05 November 2015 Pages: 493 - 498
Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases Chao TangZhen-yu ZhangLiang-fu Zhou Clinical Study 19 November 2015 Pages: 499 - 507
Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials Sun-Ho LeeClaudio E. TatsuiLaurence D. Rhines Clinical Study 07 December 2015 Pages: 509 - 517
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas Marco LosaFausto BogazziCarla Scaroni Clinical Study 27 November 2015 Pages: 519 - 525
Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms Mohamed A. HamzaCarlos Kamiya-MatsuokaVinay K. Puduvalli Clinical Study 13 November 2015 Pages: 527 - 533
Presurgical navigated TMS motor cortex mapping improves outcome in glioblastoma surgery: a controlled observational study Thomas PichtDietmar FreyPeter Vajkoczy Clinical Study 13 November 2015 Pages: 535 - 543
High-dose cytarabine salvage therapy for recurrent primary CNS lymphoma Marc C. Chamberlain Clinical Study 13 November 2015 Pages: 545 - 550
Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results Felix BoksteinDeborah T. BlumenthalAndrew A. Kanner Clinical Study 24 November 2015 Pages: 551 - 557
Pseudoprogression in glioblastoma patients: the impact of extent of resection Hun Ho ParkTae Hoon RohJong Hee Chang Clinical Study 25 November 2015 Pages: 559 - 566
Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine D. H. HeilandW. MasalhaA. Weyerbrock Clinical Study 27 November 2015 Pages: 567 - 575
Usefulness of 11C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions Atsushi WatanabeYoshihiro MuragakiYoshikazu Okada Clinical Study 26 November 2015 Pages: 577 - 583
Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme Christian HenkerThomas KriesenJürgen Piek Clinical Study 25 November 2015 Pages: 585 - 592
